Ad
Adamas (Supernus)
Emeryville CAFounded 2000100 employees
Private CapbiotechAcquiredNeurology
Platform: Gocovri Amant
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sovazumab | ADA-6097 | Phase 1 | 2 | IL-13 | NMOSDADPKD | ||
| Terazanubrutinib | ADA-4957 | Preclinical | 1 | SMN2 | LGSHeart Failure | ||
| ADA-3632 | ADA-3632 | NDA/BLA | 1 | BET | FSGSPompe |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)